QA News and Research

RSS

Voltammetry and machine learning for real-time neurotransmitter detection

Anne Andrews (UCLA) explains how voltammetry and machine learning can track multiple neurotransmitters in real time, even with overlapping signals.

From Pittcon 10 Aug 2026

Evidence shows artificial sweeteners cannot be judged as a single group

This narrative review found that non-nutritive artificial sweeteners have compound-specific and context-dependent associations with gut microbiota, metabolism, and health-related outcomes. Evidence does not support treating all sweeteners as uniformly harmful or safe, with human findings often limited or inconsistent.

23 Jul 2026

Federal tax changes reshaped local spending decisions, research finds

Increases to the standard federal tax deduction implemented in 2018 were made permanent a year ago, and researchers are beginning to understand the downstream effects on state and local municipalities.

17 Jul 2026

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Frances Arnold on directed enzyme evolution: random mutation plus smart screening, and why it changed enzyme engineering and industry.

From Pittcon 14 Jul 2026

How agentic AI is reshaping laboratory workflows

Gary Stimson of LabVantage explains how agentic AI and CORTEX support connected laboratory workflows, from UI guidance to autonomous agents.

From Pittcon 3 Jul 2026

Under-twos should avoid screen time to protect future health

Using screens during the first 1001 days of life can lead to developmental concerns for the next generation, researchers warn.

29 Jun 2026

Leica Biosystems launches AI-powered digital pathology solution in Europe, Middle East and Africa

With the Aperio GT Elite, Leica Biosystems advances digital pathology in EMEA, combining high-throughput scanning with innovative AI quality control features.

From Leica Biosystems 16 Jun 2026

Building quality into drug development for safer, faster medicines

Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.

From Thermo Fisher Scientific – Pharmaceutical and Biopharmaceutical Solutions 2 Jun 2026

BGI Genomics joins HGP2 Rare Disease Alliance to close rare disease care gap in Asia-Pacific

The HGP2 RaDiAnce-APAC initiative enhances rare disease diagnosis and genomic medicine, fostering collaboration for improved health in the Asia-Pacific region.

From BGI Genomics 12 May 2026

African health expert: genomic sequencing enables near real-time pathogen detection

Advanced genomic sequencing techniques, like mNGS, are essential for accurate pathogen detection, crucial for effective outbreak response and patient care.

From BGI Genomics 15 Apr 2026

New blood biomarker improves cancer risk detection in people with Lynch Syndrome

Researchers at The University of Texas MD Anderson Cancer Center have discovered a new blood-based biomarker that can help identify and characterize asymptomatic people with Lynch Syndrome (LS) who are more susceptible to developing cancer based on early immune detection signatures, allowing clinicians to stratify patients based on their personal risk level.

6 Apr 2026

Greater food variety at buffets may lead to overeating

At Super Bowl parties, weddings, Independence Day cookouts and Thanksgiving dinners, people celebrate with large spreads of food.

27 Feb 2026

Study reveals long-term health risks after chemotherapy for testicular cancer

A large, multi-center study recently published online in the Journal of the National Comprehensive Cancer Network (JNCCN) provides new insight into the long-term health effects of contemporary chemotherapy regimens used to treat testicular cancer, highlighting differences in renal function, cardiovascular risk, and the overall burden of chronic health conditions among survivors.

19 Feb 2026

Integrated Monte Carlo and deep learning improve radiotherapy QA

Led by Professor Fu Jin, the study addresses a critical challenge in radiation therapy: balancing the computational speed and accuracy of EPID-based dose verification.

31 Jan 2026

Investigational cancer vaccine shows early promise for cancer prevention in Lynch syndrome

The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and cancerous cells in individuals with Lynch Syndrome (LS), according to a study from researchers at The University of Texas MD Anderson Cancer Center.

16 Jan 2026